FdaApplication
ANDA 203540
Identifiers
- fda_app_no: ANDA203540
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS LTD UNIT III |
| application_type | ANDA |
| approval_date | 2024-12-19 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RALTEGRAVIR POTASSIUM | RALTEGRAVIR POTASSIUM | EQ 400MG BASE | TABLET;ORAL |
1 product